Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design

By Lu Zhi John  

Nucleic Acids Research, Vol. 36, Iss. 11, 2008-06 ,pp. : 3738-3745

Oxford University Press

Access to resources Recommend Favorite

Monitoring Antisense Oligodeoxynucleotide Activity in Hematopoietic Cells

By Sokol D.L.   Gewirtz A.M.  

Methods, Vol. 17, Iss. 3, 1999-03 ,pp. : 219-230

Academic Press

Access to resources Recommend Favorite

Artificial neural network prediction of antisense oligodeoxynucleotide activity

By Freier S.  

Nucleic Acids Research, Vol. 30, Iss. 19, 2002-10 ,pp. : 4295-4304

Oxford University Press

Access to resources Recommend Favorite

Elevated Messenger RNA Levels after Antisense Oligodeoxynucleotide Treatment in Vitro and in Vivo

By Probst J.C.   Skutella T.  

Biochemical and Biophysical Research Communications, Vol. 225, Iss. 3, 1996-08 ,pp. : 861-868

Elsevier

Access to resources Recommend Favorite

Antisense Oligodeoxynucleotide Effects on the Hypothalamic–Neurohypophysial System and the Hypothalamic–Pituitary–Adrenal Axis

By Neumann I.D.  

Methods, Vol. 22, Iss. 3, 2000-11 ,pp. : 227-237

Academic Press

Access to resources Recommend Favorite